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R E S EA R C H A R T I C L E

The Role of Voltage-Gated Calcium Channels in
Neurotransmitter Phenotype Specification:
Coexpression and Functional Analysis in
Xenopus laevis
Brittany B. Lewis, Lauren E. Miller, Wendy A. Herbst, and Margaret S. Saha*
Department of Biology, College of William and Mary, Williamsburg, Virginia 23185

ABSTRACT
Calcium activity has been implicated in many neurodevelopmental events, including the specification of neurotransmitter phenotypes. Higher levels of calcium activity lead to an
increased number of inhibitory neural phenotypes, whereas
lower levels of calcium activity lead to excitatory neural
phenotypes. Voltage-gated calcium channels (VGCCs) allow
for rapid calcium entry and are expressed during early neural stages, making them likely regulators of activitydependent neurotransmitter phenotype specification. To
test this hypothesis, multiplex fluorescent in situ hybridization was used to characterize the coexpression of eight
VGCC a1 subunits with the excitatory and inhibitory neural
markers xVGlut1 and xVIAAT in Xenopus laevis embryos.
VGCC coexpression was higher with xVGlut1 than xVIAAT,
especially in the hindbrain, spinal cord, and cranial nerves.
Calcium activity was also analyzed on a single-cell level,

and spike frequency was correlated with the expression of
VGCC a1 subunits in cell culture. Cells expressing Cav2.1
and Cav2.2 displayed increased calcium spiking compared
with cells not expressing this marker. The VGCC antagonist
diltiazem and agonist (2)BayK 8644 were used to manipulate calcium activity. Diltiazem exposure increased the number of glutamatergic cells and decreased the number of gaminobutyric acid (GABA)ergic cells, whereas (2)BayK
8644 exposure decreased the number of glutamatergic
cells without having an effect on the number of GABAergic
cells. Given that the expression and functional manipulation
of VGCCs are correlated with neurotransmitter phenotype
in some, but not all, experiments, VGCCs likely act in combination with a variety of other signaling factors to determine neuronal phenotype specification. J. Comp. Neurol.
522:2518–2531, 2014.
C 2014 Wiley Periodicals, Inc.
V
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Changes in intracellular calcium concentration are
implicated in a wide array of neurodevelopmental
events ranging from neural induction to neurite outgrowth and synapse refinement (reviewed in Rosenberg
and Spitzer, 2011; Leclerc et al., 2011). Although the
mechanisms mediating spontaneous calcium activity
during early neural development are not fully understood, it is known that voltage-gated calcium channels
(VGCCs) play a role in regulating this activity. Essential
for transducing changes in membrane potential into calcium activity that triggers cellular responses (reviewed
in Barbado et al., 2009; Catterall, 2011; Turner et al.,
2011), the family of 10 VGCC a1 subunits, which contain the pore-forming loop and determine the channel’s
physiological characteristics, is widely expressed in the
developing nervous system (Lewis et al., 2009;
Sanhueza et al., 2009; Morton et al., 2013). Moreover,
C 2014 Wiley Periodicals, Inc.
V
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calcium influx via VGCCs is known to regulate neural
plate formation (Papanayotou et al., 2013), differentiation of neural progenitor cells (Lepski et al., 2013),
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dendrite morphogenesis (Nishiyama et al., 2011), axon
outgrowth (Homma et al., 2006; Lu et al., 2009; Huang
et al., 2012), and synaptic plasticity (Kasyanov et al.,
2004; Takahashi and Magee, 2009).
A growing body of recent evidence suggests that calcium activity also plays an important and relatively novel
role during neural development, namely, mediating neurotransmitter phenotype specification. The work of Spitzer and Borodinsky has shown that higher frequencies of
calcium spiking lead to the specification of inhibitory
phenotypes, whereas lower frequencies of calcium spiking result in the specification of excitatory phenotypes, a
phenomenon that occurs both in vitro and in vivo
(reviewed in Spitzer, 2012; Borodinsky et al., 2014). Subsequent work has elucidated the molecular mechanisms
leading from calcium entry to the phenotype specification. Upregulating calcium activity via ion channel misexpression leads to the phosphorylation of cJun and
subsequent repression of transcription factor Tlx3, which
increases the number of g-aminobutyric acid (GABA)ergic
phenotypes and decreases the number of glutamatergic
phenotypes; downregulating calcium activity produces
the opposite result (Borodinsky et al., 2004; Marek et al.,
2010). However, the molecular mechanisms governing
the entry of calcium into prospective neurons remain
unknown. Given the widespread expression of the VGCCs
during neural plate and tube stages, these channels have
been hypothesized to serve as candidates for mediating
this activity-dependent neurotransmitter phenotype
specification (Spitzer et al., 2002).
To begin to test the hypothesis that VGCCs mediate
neurotransmitter phenotype choice, we have analyzed
the coexpression of the VGCC a1 subunits with markers
of glutamatergic (xVGlut1) and GABAergic or glycinergic
(xVIAAT) neurotransmitter identity in Xenopus laevis, the
species in which the role of calcium activity in neurotransmitter determination was first elucidated. Here we
show that although there is no strict one-to-one colocalization between VGCCs and neurotransmitter phenotype,
there are regions of significant colocalization. In addition,
we correlated spiking behavior with VGCC expression in
pharmacologically manipulated presumptive neurons to
demonstrate that inhibiting or activating VGCCs alters
neurotransmitter choice on a single-cell level. Taken
together, these data suggest a role for these channels in
mediating the activity associated with neurotransmitter
phenotype specification.

MATERIALS AND METHODS
Animal use
Embryos were obtained by the natural mating of
Xenopus laevis injected with human chorionic

TABLE 1.
Probe Sequences for In Situ Hybridization
Gene
Cav1.2
Cav1.3
Cav1.4
Cav2.1
Cav2.2
Cav2.3
Cav3.1
Cav3.2
xVGlut1
xVIAAT
xGAD67

Genbank accession no.

Bases

GQ120626
GQ120627
GQ120629
GQ120624
GQ120625
GQ120628
GQ120630
GQ120631
AF548627
NM_001086492
U38225

1–1,781
1–1,215
1–933
1–1,130
1–485
1–1,219
1–1,973
1–2,129
104–1,741
440–1,903
454–1,289

Antisense RNA probes were generated to hybridize to Xenopus laevis
mRNA sequences for VGCC a1 subunits and neurotransmitter phenotype markers.

gonadotropin as described by Sive et al. (2000). Staging of embryos was performed according to Nieuwkoop
and Faber (1994). Animal care and use protocols were
performed in accordance with the regulations established by the Institutional Animal Care and Use Committee at the College of William and Mary.

Whole-mount expression analysis
Antisense mRNA probes (Table 1) were generated for
eight of the VGCC a1 subunits, Cav1.2, Cav1.2, Cav1.3,
Cav1.4, Cav2.1, Cav2.3, Cav3.1, and Cav3.2, and labeled
with digoxigenin-11-UTP (Roche, Indianapolis, IN) as
previously described (Lewis et al., 2009). Antisense
mRNA probes for xVGlut1 and xVIAAT were generated
and labeled with fluorescein-12-UTP (Roche) (Gleason
et al., 2003; Wester et al., 2008). Probes were synthesized in vitro by using standard techniques as described
by Sambrook and Russell (2001). Multiplex fluorescence in situ histochemistry (FISH) analysis was performed on whole-mount Xenopus laevis early swimming
tadpole stage embryos, using tyramide signal amplification to develop fluorescein and Cy3 fluorescence as
described in Davidson and Keller (1999). For histological analysis, embryos were fixed in 1.6 M sucrose in
phosphate-buffered saline for at least 12 hours at 4 C,
embedded in tissue freezing medium (Triangle Biomedical Sciences, Durham, NC) at 220 C, cryosectioned
into 18-lm transverse slices, and mounted onto slides
for imaging using laser scanning confocal microscopy
(Zeiss LSM 510). Histological sections were imaged at
the 203 objective, with a zoom of 13 for brain and
spinal cord images and a zoom of 1.23 for retinal
images.
Images were taken by using the green fluorescein
channel (excitation 488 nm, laser power 3.1%) and the
red Cy3 channel (excitation 543 nm, laser power 14.9–
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16.9%). Detector gain and amplifier offset were
adjusted for both channels to acquire an optimal signal.
Detector gain was increased until regions showing signal saturated the photomultiplier tube and background
regions did not. Amplifier offset was decreased until
the intensity of background regions dropped just below
the level of detection. “Coexpression” was defined as
red and green signal present in the same cell, as indicated by yellow signal in the composite image.

Primary cell culture
Neural tissue was dissected from stage 14, 18, and
22 Xenopus laevis embryos in modified Ringer’s solution
(MR) (Chang and Spitzer, 2009) supplemented with 1
mg/ml collagenase B (Roche) to facilitate dissections.
After dissection, explants were transferred to a calciumand magnesium-free (CMF) solution (Gu et al., 1994)
and allowed to dissociate for 1 hour. Cells were plated
on 35-mm Nunclon dishes (Cellattice; Nexcelom, Lawrence, MA) containing MR and were allowed to settle to
the bottom of the plate for 1 hour. All steps of this procedure were performed at room temperature (22 C).

fluorescence 50% above the baseline (0.5 units above
the baseline of 1).

Pharmacology
Neural tissue was dissected and dissociated in the
same manner as calcium-imaged cultures, at the neural
plate (st. 14), neural fold (st. 18), and neural tube (st.
22) stages. Cells were plated in MR containing 10 lM
or 100 lM diltiazem (Sigma, St. Louis, MO), 1 lM or
10 lM (2)BayK-8644 (Sigma), MR alone, or MR with
0.05% dimethylsulfoxide (DMSO; BayK-8644 experiments only). The concentrations of diltiazem used in
these experiments have previously been demonstrated
to decrease calcium currents for VGCC a1 subunits in
cell culture (Cai et al., 1997; De Paoli et al., 2002), and
the concentrations of (2)BayK 8644 used were shown
to increase calcium activity in amphibian explants and
cell culture (Moreau et al., 1994; Takano et al., 2011).
Cultures were fixed in 1X MEMFA when intact sibling
embryos reached the swimming tadpole stage (35–36),
and then stored in ethanol at 220 C.

Expression analysis in primary cell culture
Calcium imaging
For calcium imaging experiments, cells were incubated in 2.5 lM Fluo4-AM (Invitrogen Molecular Probes,
Carlsbad, CA) with 0.01% Pluronic F-127 for 1 hour at
room temperature. Cells were rinsed with MR in three
successive washes. Two hours after they were initially
plated, cells were imaged with confocal laser scanning
microscopy (Zeiss LSM 510). Calcium imaging was
recorded for 2 hours. The Argon 488-nm laser was set
to 4% of its maximum 30 mW power, and the plate was
scanned every 8 seconds for a total of 900 frames.
Cells were fixed in 1X MEMFA for 30 minutes and dehydrated in 100% ethanol (Sive et al., 2000).

Calcium activity analysis
Calcium activity was examined by using ImageJ (NIH).
Stationary cells were circled manually to create regions
of interest (ROIs). Average fluorescence intensity was
examined in each of the 900 frames acquired during
the calcium image and normalized to account for the
gradual increase in baseline intensity seen in all cells
due to gradual photo-bleaching, according to the equation: F 5 (FR 2 FB)/(F0 2 FB), where FR is the raw fluorescence value within the ROI, FB is background
fluorescence, F0 is the average fluorescence of the past
10 frames, and F is the normalized value of the fluorescence intensity. This normalization process could result
in an apparent undershoot if the raw fluorescence value
of the current frame is below the average value of the
previous 10 frames. Spikes were defined as a rise in
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Antisense mRNA probes (Table 1) were generated for
Cav1.2, Cav1.2, Cav1.3, Cav1.4, Cav2.1, Cav2.3, Cav3.1,
Cav3.2 (Lewis et al., 2009), xVGlut1 (Gleason et al.,
2003), and xGAD67 (Li et al., 2006) and used for
expression analysis. Whereas xVIAAT was selected as a
general inhibitory neural marker in whole-mount coexpression experiments, the specifically GABAergic probe
xGAD67 was selected for cell culture experiments
because previous studies have demonstrated that calcium spike frequency regulates xGAD67 expression in
vitro (Watt et al., 2000). High-stringency FISH was performed on cell cultures using an anti-digoxigenin peroxidase antibody (Roche) and fluorescein–tyramide as the
color substrate, following the protocol of Davidson and
Keller (1999) with minor modifications as outlined by
McDonough et al. (2012). Sense probes were used to
determine background level of fluorescence.

Statistical analysis of calcium-imaged plates
ROIs were divided into three categories: “positives,”
those expressing the gene of interest, “negatives,”
those not expressing the gene, and “unknowns,” cells
that washed from the plate between calcium imaging
and in situ hybridization analysis. The Mann–Whitney
U-test was utilized to rank ROIs according to the number of spikes exhibited during the 2-hour image and to
compare the activity in positive and negative ROIs,
using programs written with MATLAB (MathWorks,
Natick, MA). P values 0.05 were considered
significant.
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TABLE 2.
Classification of coexpression patterns of VGCC a1 subunits and xVGlut1

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Cav1.2 cx
vGlut cx
Cav1.3 cx
vGlut cx
Cav1.4 cx
vGlut cx
Cav2.1 cx
vGlut cx
Cav2.2 cx
vGlut cx
Cav2.3 cx
vGlut cx
Cav3.1 cx
vGlut cx
Cav3.2 cx
vGlut cx

Forebrain

Midbrain

Hindbrain

Spinal Cord

Retina

Cranial Nerves

1
11
1
11
N/A
N/A
1
11
1
1
N/A
N/A
-

11
11
N/A
N/A
11
111
1
11
1
1
1
111
1
1

1
1
111
11
N/A
N/A
1
1
11
11
1
1
111
111
1
1

1
11
111
111
N/A
N/A
1
11
111
111
111
111
11
11

1
1
1
1
1
11
N/A
N/A
1
1
1
1

111
111
N/A
N/A
111
111
111
111
1
1
111
111
11
11

For each coexpression (cx) experiment, the relative percentage of cells expressing both the VGCC subunit and xVGlut1 (yellow FISH signal in Figs.
1-2) out of the total number of cells expressing the VGCC subunit (green and yellow FISH signal in Figs. 1-2) was determined. Additionally, the relative percentage of cells expressing both the VGCC subunit and xVGlut1 (yellow FISH signal) out of the total number of cells expressing xVGlut1 (red
and yellow FISH signal) was determined. A single plus sign (1) indicates that <25% of the cells expressing the marker displayed coexpression.
Two plus signs (11) indicates that 25–75% of the cells expressing the marker displayed coexpression, and three plus signs (111) indicates
>75% coexpression. Full coexpression between the two markers (>90%) is indicated in bold. Experiments without coexpression are marked with a
minus sign (2).

Statistical analysis of pharmacologically
exposed plates
The number of cells expressing the neurotransmitter
phenotype marker of interest was counted, and the proportion of positive cells was compared among treatment and control plates using the two-sample z-test. P
values  0.05 were considered significant.

RESULTS
Coexpression of VGCC a1 subunits with
xVGlut1
To determine which, if any, VGCC a1 subunits are
coexpressed with excitatory neurotransmitter markers,
multiplex FISH analysis was performed, probing for
VGCC markers and xVGlut1. VGCC a1 subunits are
highly coexpressed with the glutamatergic marker
throughout the developing nervous system, although
many neurons expressing VGCCs do not express the
neurotransmitter marker and vice versa (Table 2). In the
forebrain, xVGlut1 is coexpressed with Cav1.2 in the
dorsalmost tip (Fig. 1A), whereas overlap of Cav1.3 and
xVGlut1 occurs in a medial band extending from the
dorsal end of the forebrain (Fig. 1F). xVGlut1 coexpression also occurs along the lateral edge of the forebrain
with Cav2.1 and Cav2.2 (Fig. 1K,P). Coexpression in the
midbrain is highest between xVGlut1 and Cav3.1 and is
found in a ventral lateral region (Fig. 1U). xVGlut1 coexpression is also found with Cav1.2 and Cav2.1 in the lat-

eral midbrain (Fig. 1B,L). xVGlut1 is coexpressed with
Cav1.3 and Cav3.1 in the ventral hindbrain and in the
spinal cord interneurons (Fig. 1H–J,V,W). Additional
coexpression occurs with Cav2.2 along the lateral edge
of the spinal cord (Fig. 1S). Very little coexpression is
found in the retina, although Cav2.1 and xVGlut1 do
overlap in the ganglion cell layer (GCL) (Fig. 2D). In the
cranial nerves, coexpression is found between xVGlut1
and VGCCs in every cell in this region (Fig.
1G,M,R,V,W,Y,Z).

Coexpression of VGCC a1 subunits with
xVIAAT
To determine whether VGCC a1 subunits are coexpressed with inhibitory neurotransmitter markers, multiplex FISH analysis was performed, probing for VGCCs
and xVIAAT. To a lesser extent, VGCC a1 subunits are
coexpressed with the inhibitory neural marker (Table 3).
Forebrain and midbrain coexpression is restricted to ventral regions and occurs most prominently with Cav1.2,
Cav2.1, and Cav2.2 (Fig. 3A,B,K,L,P,Q). Hindbrain coexpression is located dorsally and occurs with Cav1.2,
Cav1.3, and Cav2.2 (Fig. 3C,H,R). In the spinal cord, coexpression is found with Cav1.2, Cav1.3, Cav2.1, and Cav2.2
in the inhibitory commissural reciprocal interneurons
(cINs) and ascending recurrent interneurons (aINs) (Fig.
3D,I,N,S). Retina coexpression occurs in the inner
nuclear layer (INL) with Cav2.1 and Cav2.2 (Fig. 4D,E).
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Cav2.1 and Cav2.2 are correlated with highfrequency calcium activity at specific developmental stages

expressing glutamatergic cells while having no effect on
the number of GABAergic cells. (Fig. 8C,D)

After determining the coexpression of VGCC a1 subunits with neurotransmitter markers in whole-mount
embryos, VGCC expression was correlated with calcium
activity in primary cell culture. Expression was assessed
at the neural plate (st. 14), neural fold (st. 18), and
neural tube (st. 22) stages by using FISH. Cav1.2,
Cav2.1, Cav2.2, and Cav3.2 are the only channels
detected in cultures dissected at the neural plate stage
(Fig. 5). Whereas Cav2.1, Cav2.2, and Cav3.2 are subsequently expressed at neural fold and neural tube stage
dissections, Cav1.2 is not detected in cells cultured
after the neural plate stage. Cav1.3 is detected in cell
cultures dissected at the neural tube stage.
As the only VGCC a1 subunits expressed in cultured
cells dissected at neural plate, neural fold, and neural
tube stages, Cav1.2, Cav1.3, Cav2.1, Cav2.2, and Cav3.2
were examined further in calcium activity imaging
experiments (Fig. 6). Two-hour calcium images were
performed on neuronal cell culture, and spiking data
were analyzed in three 40-minute time blocks. The
number of calcium spikes in cells with VGCC expression (positive cells) was compared with the number of
spikes in cells without detectable expression (negative
cells). Cav2.1 is correlated with high-frequency calcium
activity in cell cultures dissected at the neural plate
and neural fold stages (Fig. 7A) and Cav22.22 is correlated with high-frequency calcium activity in neural tube
cultures (Fig. 7B). The Cav1.2-, Cav1.3-, and Cav3.2-positive cells have equal spiking activity compared with
cells negative for these markers.

DISCUSSION
Coexpression of VGCC a1 subunits with
neurotransmitter phenotype markers

Pharmacological disruption of VGCC activity
leads to changes in neurotransmitter
phenotype specification
Because VGCCs are expressed in neural tissue during
early development and certain VGCCs are correlated
with specific spike frequencies in cell culture, the effect
of the VGCC blocker diltiazem and agonist (2)Bayk
8644 on neurotransmitter phenotype specification was
examined next. The percentage of cells expressing
xVGlut1 or xGAD67 was assessed among treatment
conditions, and a two-sample z-test was used to compare the percentage of positive cells in cultures
exposed to diltiazem or (2)BayK 8644 with untreated
controls. Exposure to the VGCC antagonist leads to an
increase in glutamatergic neurons and a decrease in
GABAergic neurons (Fig. 8A,B). Exposure to the VGCC
agonist significantly decreases the percentage of cells

2522

The goal of this study was to test the hypothesis that
calcium signaling through VGCCs, at least in part, modulates neurotransmitter phenotype specification in developing Xenopus laevis embryos. An obvious prediction of
this hypothesis is a clear pattern of colocalization of specific VGCCs with markers of neurotransmitter phenotype,
at least on a regional level. Although coexpression experiments demonstrated that no VGCC a1 subunit has a simple one-to-one pattern of colocalization with either
xVGlut1 or xVIAAT, in most regions examined, VGCCs are
coexpressed with xVGlut1 or xVIAAT in some neurons,
but VGCC expression is also found in neurons not
expressing either of these markers. Conversely, xVGlut1
and xVIAAT are found in neurons not expressing VGCC
a1 subunits. However, several VGCC a1 subunits display
preferential colocalization with either xVGlut1 or xVIAAT.
Cav1.3 is coexpressed more frequently with xVGlut1
whereas Cav1.2 and Cav3.1 are coexpressed more frequently with xVIAAT. This differential expression suggests
that specific VGCC subunits could mediate the determination of excitatory and inhibitory neurotransmitter phenotypes. Although Cav2.1 and Cav2.2 both display tight
coexpression patterns, they are correlated with both
xVGlut1 and xVIAAT depending on the specific region
(Tables 1, 2).
A caveat to this analysis is that VGCC a1 subunits
display extensive alternative splicing (Rajapaksha et al.,
2008; Zhang et al., 2010; Gardezi et al., 2010; Tuluc
and Flucher, 2011; Tan et al., 2012). These variants
have different functional characteristics, which can alter
the sensitivity of depolarization-dependent calcium signaling across development and in different regions of
the nervous system (reviewed in Lipscombe et al.,
2013). It is possible that specific splice isoforms of
VGCCs are important in the determination of particular
neurotransmitter phenotypes. Because the probes used
in these experiments may bind multiple splice isoforms
of each VGCC a1 subunit, the patterns observed in
colocalization experiments could include several individual patterns. Similarly, because xVIAAT marks both
GABAergic and glycinergic phenotypes, there may be
patterns of colocalization between particular VGCCs
and either of these two phenotypes that cannot be distinguished in these experiments.
It is also important to note that the process of neurotransmitter phenotype specification likely occurs at
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Figure 1.
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TABLE 3.
Classification of coexpression patterns of VGCC a1 subunits and xVIAAT

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Cav1.2 cx
VIAAT cx
Cav1.3 cx
VIAAT cx
Cav1.4 cx
VIAAT cx
Cav2.1 cx
VIAAT cx
Cav2.2 cx
VIAAT cx
Cav2.3 cx
VIAAT cx
Cav3.1 cx
VIAAT cx
Cav3.2 cx
VIAAT cx

Forebrain

Midbrain

Hindbrain

Spinal Cord

Retina

Cranial Nerves

11
11
1
1
N/A
N/A
1
11
11
11
N/A
N/A
1
1

1
11
1
1
N/A
N/A
1
111
1
11
1
1
1
1
1
1

1
11
11
11
N/A
N/A
1
1
11
1
1
1
1
1
1

1
11
1
11
N/A
N/A
1
11
1
11
1
1
1
1
1
1

1
1
1
1
11
111
11
11
N/A
N/A
1
1
1
11

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

For each coexpression (cx) experiment, the relative percentage of cells expressing both the VGCC subunit and xVIAAT (yellow FISH signal in Figs.
3-4) out of the total number of cells expressing the VGCC subunit (green and yellow FISH signal in Figs. 3-4) was determined. Additionally, the relative percentage of cells expressing both the VGCC subunit and xVIAAT (yellow FISH signal) out of the total number of cells expressing xVIAAT (red
and yellow FISH signal) was determined. A single plus sign (1) indicates that <25% of the cells expressing the marker displayed coexpression.
Two plus signs (11) indicates that 25–75% of the cells expressing the marker displayed coexpression, and three plus signs (111) indicates
>75% coexpression. Experiments without coexpression are marked with a minus sign (2).

Figure 2. Coexpression patterns of xVGlut1 and VGCC a1 subunits in the retina of Xenopus laevis swimming tadpole embryos. VGCC subunit
expression is labeled with fluorescein (green), and xVGlut1 expression is labeled with Cy3 (red). Coexpression is indicated by the yellow overlap of
both channels. A–G: xVGlut1 coexpression with (A) Cav1.2, (B) Cav1.3, (C) Cav1.4, (D) Cav2.1, (E) Cav2.2, (F) Cav3.1, and (G) Cav3.2. For the assistance of color-blind readers, a magenta–green copy of this figure is provided as Supplementary Figure 2. Scale bar 5 250 lm in A (applies to A–G).

Figure 1. Coexpression patterns of xVGlut1 and VGCC a1 subunits in the central nervous system of Xenopus laevis swimming tadpole
embryos. VGCC subunit expression is labeled with fluorescein (green), and xVGlut1 expression is labeled with Cy3 (red). Coexpression is
indicated by the yellow overlap of both channels. A–E: Cav1.2 coexpression with xVGlut1 in the (A) forebrain, (B) midbrain, (C) hindbrain, (D)
anterior spinal cord, (E) and posterior spinal cord. F–J: Cav1.3 coexpression in the (F) forebrain, (G) midbrain, (H) hindbrain, (I) anterior spinal cord, (J) and posterior spinal cord. K–O: Cav2.1 coexpression in the (K) forebrain, (L) midbrain, (M) hindbrain, (N) anterior spinal cord,
and (O) posterior spinal cord. P–S: Cav2.2 coexpression in the (P) forebrain, (Q) midbrain, (R) hindbrain, (S) spinal cord. T–AA: Cav3.1 coexpression in the (T) forebrain, (U) midbrain, (V) hindbrain, (W) spinal cord. Cav3.2 coexpression in the (X) forebrain, (Y) midbrain, (Z) hindbrain,
and (AA) spinal cord. BB–DD: Cav2.3 coexpression in the (BB) midbrain, (CC) hindbrain, and (DD) spinal cord. For the assistance of colorblind readers, a magenta–green copy of this figure is provided as Supplementary Figure 1. Scale bar 5 100 lm in A (applies to A–DD).

VGCCs and neuronal phenotype

Figure 3.
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earlier stages of Xenopus development than the stage
examined in this study (early swimming tadpole). However, the expression patterns of VGCCs and neurotransmitter markers examined in this study are spatially
consistent across Xenopus embryonic development
(Gleason et al., 2003; Wester et al., 2008; Lewis et al.,
2009), and coexpression patterns at later stages are
indicative of coexpression at earlier stages. The swimming tadpole stage was selected for analysis because of
the robust expression of VGCCs and neural markers.
Additionally, coexpression of VGCCs and neurotransmitter markers may continue at these later stages,
to maintain the appropriate neural phenotype. Neurotransmitter identity is not a stable fate; even after synapses have formed, changes in electrical activity can
respecify the neurotransmitters expressed in a given neuron (reviewed in Spitzer, 2012). Neurotransmitter respecification is known to occur in the ventral suprachiasmic
nucleus (vSCN), where dopaminergic neurons are
recruited in response to increased sensory input (Dulcis

and Spitzer, 2008). In the mossy fiber projection of the
hippocampus in the adult brain, exclusively glutamatergic
transmission is respecified to simultaneous glutamatergic
and GABAergic signaling, in response to physiological
stimulation of the dentate gyrus (Gutierrez, 2002). Maintaining the appropriate neurotransmitter phenotype is
ongoing, and the mechanisms that regulate this process,
including electrical activity via VGCCs, are likely to persist
throughout development.

VGCC expression as a marker for neuronal
subtypes
Although there was not a robust correlation between
VGCC expression and neurotransmitter phenotype, the
detailed characterization of these neural genes throughout the developing vertebrate nervous system can be
used to identify subpopulations of neurons. Whereas
the spatial expression of excitatory and inhibitory neurotransmitter phenotypes has been characterized during

Figure 4. Coexpression patterns of xVIAAT and VGCC a1 subunits in the retina of Xenopus laevis swimming tadpole embryos. VGCC subunit
expression is labeled with fluorescein (green), and xVIAAT expression is labeled with Cy3 (red). Coexpression is indicated by the yellow overlap of
both channels. A–G: xVIAAT coexpression with (A) Cav1.2, (B) Cav1.3, (C) Cav1.4, (D) Cav2.1, (E) Cav2.2, (F) Cav3.1, and (G) Cav3.2. For the assistance of color-blind readers, a magenta–green copy of this figure is provided as Supplementary Figure 3. Scale bar 5 250 lm in A (applies to A–G).

Figure 3. Coexpression patterns of xVIAAT and VGCC a1 subunits in the central nervous system of Xenopus laevis swimming tadpole
embryos. VGCC subunit expression is labeled with fluorescein (green) and xVIAAT expression is labeled with Cy3 (red). Coexpression is indicated by the yellow overlap of both channels. A–D: Cav1.2 coexpression with xVIAAT in the (A) forebrain, (B) midbrain, (C) hindbrain, (D)
anterior spinal cord, and (E) posterior spinal cord. F–J: Cav1.3 coexpression in the (F) forebrain, (G) midbrain, (H) hindbrain, (I) anterior spinal
cord, and (J) posterior spinal cord. K–O: Cav2.1 coexpression in the (K) forebrain, (L) midbrain, (M) hindbrain, (N) anterior spinal cord, and
(O) posterior spinal cord. P–S: Cav2.2 coexpression in the (P) forebrain, (Q) midbrain, (R) hindbrain, and (S) spinal cord. Cav3.1 coexpression
in the (T) forebrain, (U) midbrain, (V) hindbrain, and (W) spinal cord. X–AA: Cav3.2 coexpression in the (X) forebrain, (Y) midbrain, (Z) hindbrain, and (AA) spinal cord. BB–DD: Cav2.3 coexpression in the (BB) midbrain, (CC) hindbrain, and (DD) spinal cord. For the assistance of
color-blind readers, a magenta–green copy of this figure is provided as Supplementary Figure 4. Scale bar 5 100 lm in A (applies to A–DD).
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early embryogenesis throughout the developing brain
(Gleason et al., 2003; Wester et al., 2008), spinal cord
(reviewed in Roberts et al., 2012), and retina (Dullin
et al., 2007), the specific VGCCs expressed in neural
subpopulations is less well known. Several studies have
characterized the expression of VGCCs during embryogenesis (Zhou et al., 2008; Lewis et al., 2009; Sanhueza
et al., 2009), but this is the first comprehensive study to
describe the expression of calcium channels and neural
phenotype markers together. Coexpression patterns
demonstrate which VGCCs are expressed in specific
inhibitory and excitatory neural subpopulations.
Histological analysis revealed that, in many instances,
VGCCs are expressed in discrete, highly specific regions

Figure 5. Expression of VGCCs in cultured cells. Expression of
the five VGCC a1 subunits detected with FISH in neural cell cultures during early development. Cav1.2 and Cav1.3 are detected
at neural plate and neural tube stages, respectively. Cav2.1,
Cav2.2, and Cav3.2 are detected throughout the developmental
period studied. Cav2.1 and Cav2.2 are expressed at highest levels
at the neural fold stage, and Cav3.2 expression is highest at the
neural tube stage. At the neural plate stage, n 5 280 cells
(Cav1.2), 339 cells (Cav2.1), 358 cells (Cav2.2), and 578 cells
(Cav3.2). At the neural fold stage, n 5 376 cells (Cav2.1), 305
cells (Cav2.2), and 403 cells (Cav3.2). At the neural tube stage,
n 5 1,843 cells (Cav1.3), 1,227 cells (Cav2.1), 1,197 cells
(Cav2.2), and 631 cells (Cav3.2).

of the nervous system. This distinct patterning of VGCCs
may contribute to a diverse array of physiological properties in these neural subpopulations. The expression of
Cav1.2 in the inhibitory subpopulations of the dorsal spinal cord (cINs and aINs) is of note, because this VGCC is
strongly implicated in regulating neural gene expression
and plasticity by activation of CREB (Dolmetsch et al.,
2001; Wheeler et al., 2008). The glutamatergic descending interneurons (dINs) in the ventral spinal cord were
found to express two developmentally important VGCCs:
Cav1.3, which contributes to calcium oscillations in pacemaker neurons (Guzman et al., 2009; reviewed in Vandael et al., 2013), and Cav2.1, which mediates
neurotransmitter release and is involved in synaptic competition (Hashimoto et al., 2011) and plasticity (Mochida
et al., 2008; reviewed in Catterall et al., 2013). Knockout
models have further demonstrated the neurodevelopmental importance of these VGCCs; Cav2.1 knockout
mice display developmental abnormalities in in the cerebellum, including axonal swelling of Purkinje cells and a
deficit in external granule cell layer (Jun et al., 1999), and
Cav1.3 knockout mice have underdeveloped auditory
brainstems with significantly fewer neurons in the lateral
superior olive (Hirtz et al., 2011). Additionally, Cav1.3
knockout mice display elevated levels of glutamate,
GABA, and serotonin, suggesting that VGCCs are necessary for the normal expression of neurotransmitters
(Sagala et al., 2012).

Correlation of calcium activity, VGCC
expression, and neurotransmitter phenotype
in cell culture
Although previous research shows that global manipulation of calcium activity leads to changes in the proportion of GABAergic and glutamatergic neurons in
Xenopus embryos, no studies to date have investigated
the relationships among calcium activity, VGCC expression, and neurotransmitter phenotype at a single-cell

Figure 6. Sample image set from calcium imaging. A: Average brightfield image of cells during calcium imaging. B: Average Fluo4 fluorescence image of cells during calcium imaging. Bright regions indicate cells with high levels of calcium transients. C: Fluorescent image of
cells after FISH. Positive cells are circled. D: Sample calcium activity data from a region of interest (ROI).
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Figure 7. Cav2.1 and Cav2.2 activity. A,B: Comparison of calcium activity in cells exhibiting positive expression for Cav2.1 (A) and Cav2.2
(B) with cells displaying no detectable expression for this VGCC (negative cells). Activity for the cells was analyzed over a 2-hour imaging
session, and each dissection (st.14, 18, or 22) was divided into three time blocks. A single time block represents 40 minutes of the
image, i.e., “a” is t 5 0 to t 5 40 minutes, “b” is t 5 40 minutes to t 5 80 minutes, and “c” is t 5 80 minutes to t 5 120 minutes. Numbers
of spikes in positive and negative cells were compared using the Mann–Whitney U-test. Comparisons with P values  0.05 are marked
with an asterisk (*) on the figure. For Cav2.1 experiments, n 5 340 cells (neural plate), 294 cells (neural fold), and 1,228 cells (neural
tube). For Cav2.2 experiments, n 5 357 cells (neural plate), 139 cells (neural fold), and 1,197 cells (neural tube).

level. This study demonstrates that, of the five VGCC a1
subunits detected in cell cultures, expression of Cav2.1
and Cav2.2 is correlated most strongly with high frequencies of calcium activity. Specifically, cells cultured at the
neural plate and neural fold stages that express Cav2.1
have higher spike counts during the 2-hour image than
cells with no detectable expression and, at the neural
tube stage, cultured cells that express Cav2.2 have a significantly higher spike frequency than cells with no
expression for this VGCC. Interestingly, these two VGCC
subunits display the highest coexpression with both
inhibitory and excitatory neural markers.
The other three VGCCs with positive expression in
culture, Cav1.2, Cav1.3, and Cav3.2, are not associated
with increased calcium activity in the time period examined, despite the coexpression patterns implying that
Cav1.2 and Cav1.3 play a role in neurotransmitter phenotype specification, given their preferential coexpression with xVIAAT and xVGlut1, respectively. Because
some VGCC a1 subunits are correlated with specific
patterns of calcium activity, the effect of VGCC antagonist application on cultured cells was examined next.
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Cultured cells exposed to diltiazem express significantly
more xVGlut1-positive cells and significantly fewer
xGAD67-positive cells than untreated controls. The
upregulation of the excitatory neurotransmitter marker
xVGlut1 in response to decreased calcium activity
agrees with the result found by Borodinsky et al.
(2004): injection of potassium channel mRNA to hyperpolarize cell membranes and decrease activity resulted
in greater immunoreactivity to the excitatory transmitters glutamate and acetylcholine. The concomitant
decrease in xGAD67 mRNA expression seen in
response to diltiazem exposure also supports the
homeostatic model of neurotransmitter phenotype specification (Spitzer et al., 2005). Cultured cells exposed to
(2)BayK 8644 express significantly fewer xVGlut1 cells
than control cultures at the neural plate, neural fold,
and neural tube stages. However, the percentage of
xGAD67-positive cells is similar in (2)BayK 8644 and
control cultures, which suggests that other signaling
factors contribute to neurotransmitter phenotype specification and, in certain cases, prevail over the effects of
VGCC activation.
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Figure 8. Pharmacological disruption of VGCC activity and neurotransmitter phenotype. Embryos were dissected at neural plate, neural
fold, and neural tube stages, incubated in either a VGCC antagonist (diltiazem) or a VGCC agonist (BayK 8644), and then assayed for
expression of the glutamatergic marker xVGlut1 or the GABAergic marker xGAD67. The number of cells expressing the gene of interest
(termed “positives”) and the number of cells not expressing the gene of interest (termed “negatives”) for representative fields of view
were recorded. A two-sample z-test was used to compare the percent positive between treatment groups and controls. P  0.05 was
recorded as significant. A: xVGlut1 expression of diltiazem-exposed cells. B: xGAD67 expression of diltiazem-exposed cells. C: xVGlut1
expression of BayK 8644-exposed cells. D: xGAD67 expression of BayK 8644-exposed cells. For diltiazem exposures with xVGlut1 expression, n 5 1,398 cells (0 lM, neural plate), 1,069 cells (10 lM, neural plate), 936 cells (100 lM, neural plate), 909 cells (0 lM, neural
fold), 1,003 cells (10 lM, neural fold), 1,160 cells (100 lM, neural fold), 2,419 cells (0 lM, neural tube), 1,147 cells (10 lM, neural
tube), and 160 cells (100 lM, neural tube). For diltizem exposures with xGAD67 expression, n 5 1,259 cells (0 lM, neural plate), 843 cells
(10 lM, neural plate), 658 cells (100 lM, neural plate), 576 cells (0 lM, neural fold), 1,523 cells (10 lM, neural fold), 1,441 cells (100
lM, neural fold), 1,486 cells (0 lM, neural tube), 1,509 cells (10 lM, neural tube), and 1,171 cells (100 lM, neural tube). For BayK 8644
exposures with xVGlut1 expression, n 5 1,178 cells (0 lM, neural plate), 1,817 cells (10 lM, neural plate), 1,755 cells (100 lM, neural
plate), 1,222 cells (0 lM, neural fold), 1,249 cells (10 lM, neural fold), 1,126 cells (100 lM, neural fold), 1,455 cells (0 lM, neural tube),
1,384 cells (10 lM, neural tube), and 1,519 cells (100 lM, neural tube). For BayK 8644 exposures with xGAD67 expression, n 5 851 cells
(0 lM, neural plate), 1,777 cells (10 lM, neural plate), 1,075 cells (100 lM, neural plate), 1,018 cells (0 lM, neural fold), 674 cells (10
lM, neural fold), 745 cells (100 lM, neural fold), 1,560 cells (0 lM, neural tube), 1,469 cells (10 lM, neural tube), and 1,001 cells (100
lM, neural tube).

Many other receptors and ion channels are known to
regulate early calcium signaling and are therefore likely
candidates for mediating calcium-dependent neurotransmitter phenotype specification. Purinergic receptors, which include the ionotropic P2X family and the
metabotropic P2Y family, are expressed as early as gastrula and neurula stages of development (reviewed in
Mass
e and Dale, 2012). ATP signaling via purinergic
receptors can induce calcium transients that are implicated in neural differentiation (reviewed in Glaser et al.,
2013). It has been proposed that transient receptor
potential cation channels (TRPCs), which allow calcium
and sodium ions into the cell, may mediate calcium
activity during development (reviewed in Leclerc et al.,
2011). TRPCs are expressed as early as the blastula

stages of Xenopus laevis and have been implicated in
the production of calcium transients induced by fibroblast growth factor (FGF) signaling (Lee et al., 2009).
TRPCs are involved in neurodevelopmental events
including the guidance of Xenopus neuronal growth
cones (Shim et al., 2005; Kerstein et al., 2013) and
evoking calcium transients during rat neural stem cell
proliferation (Fiorio Pla et al., 2005). These alternate
mechanisms could explain why only a few VGCC a1
subunits were correlated with activity, why functional
manipulation of VGCCs did not always alter neurotransmitter phenotype, and, in the aforementioned coexpression experiments, why neuronal phenotype markers
were found in many regions in the absence of VGCCs.
Further study will be needed to characterize the role of
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other calcium-related channels and receptors in
activity-dependent
neurotransmitter
phenotype
specification.
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